comprehensive -WSS

comprehensive

author：focus 2025-09-30 06:34:41 Page View：7593

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Doudna institute plans to 'cure hundreds of diseases' with CRISPR
Next article： Activists slam private health insurers over coverage restrictions

explore

New air purifier tech could be key to improving indoor air quality

AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

Paying for Covid pills will soon shift to insurers

PayingforCovidpills,includingPaxlovid,willshifttoinsurersstartingnextweek.JoeRaedle/GettyImagesWASHI

Continuity nursing helped my family in our darkest PICU moments

EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

Physician subsidies by hospitals soar in wake of No Surprises Act

AdobePhysicianstaffingfirms,flailinginthewakeofafederallawbanningsurprisebills,aredemandingextrapaym